Euthalia Roussou

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

Martín Rudwaleit, Désirée van der Heijde, R. B. M. Landewé et al. · Annals of the Rheumatic Diseases · 2009 · 3.6K citations · Full text

Medicine, Radiology, Musculoskeletal Medicine +11

The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general

Martín Rudwaleit, D. van der Heijde, R. B. M. Landewé et al. · Annals of the Rheumatic Diseases · 2010 · 1.7K citations · Full text

Medicine, Dermatology, Internal Medicine +16

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

Peter Nash, Bruce Kirkham, Masato Okada et al. · The Lancet · 2017 · 405 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)

Philip Helliwell, Oliver FitzGerald, Jaap Fransen et al. · Annals of the Rheumatic Diseases · 2012 · 319 citations

Medicine, Biostatistics, Clinical Sciences +14

Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome

Simon Bowman, Colin Everett, John O’Dwyer et al. · Arthritis & Rheumatology · 2017 · 264 citations · Full text

Medicine, Immunology, Pharmacotherapy +14